DF
ALXN

Donoghue Forlines’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Donoghue Forlines’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-6,194
Closed -$947K – 260
2021
Q1 		$947K Sell
6,194
-793
-11% -$121K 0.18% 135
2020
Q4 		$1.09M Buy
+6,987
New +$1.09M 0.21% 129
2017
Q4 		– Sell
-16,332
Closed -$2.29M – 150
2017
Q3 		$2.29M Buy
+16,332
New +$2.29M 0.24% 73